Carbon-based nanomaterials for CRISPR/Cas delivery: a perspective on the design approach
Source abstract
Abstract
This perspective article delves into the evolving landscape of non-viral vectors for efficient CRISPR delivery, addressing the challenges associated with viral vectors and highlighting the potential of carbon-based nanomaterials as promising alternatives. The article underscores the importance of design strategies in enhancing the interactions between CRISPR components and carbon-based nanomaterials. Various design approaches are explored, including the incorporation of modified nanoparticles between carbonic layers and the creation of unique morphologies to facilitate optimal CRISPR interactions. Specific case studies are presented to exemplify the effectiveness of carbon-based nanomaterials in CRISPR delivery. This perspective sheds light on the dynamic field of non-viral CRISPR delivery vectors, emphasizing the significance of design strategies and showcasing the promising outcomes achieved through the utilization of carbon-based nanomaterials. The provided insights contribute to the ongoing efforts to develop efficient and safe methods for gene delivery and therapy. Graphical abstract
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: CRISPR and Genetic Engineering · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Wirth T, Parker N, Ylä-Herttuala S (2013) History of gene therapy. Gene 525(2):162–16910.1016/j.gene.2013.03.137 ↗
2. Dunbar CE et al (2018) Gene therapy comes of age. Science 359(6372):eaan467210.1126/science.aan4672 ↗
3. Rabiee N et al (2021) Bio-multifunctional noncovalent porphyrin functionalized carbon-based nanocomposite. Sci Rep 11(1):660410.1038/s41598-021-86119-z ↗
4. Ma C-C et al (2020) The approved gene therapy drugs worldwide: from 1998 to 2019. Biotechnol Adv 40:10750210.1016/j.biotechadv.2019.107502 ↗
5. Uddin F, Rudin CM, Sen T (2020) CRISPR gene therapy: applications, limitations, and implications for the future. Front Oncol 10:138710.3389/fonc.2020.01387 ↗
6. Ferrari G, Thrasher AJ, Aiuti A (2021) Gene therapy using haematopoietic stem and progenitor cells. Nat Rev Genet 22(4):216–23410.1038/s41576-020-00298-5 ↗
7. Ikawa Y et al (2019) Gene therapy of hemoglobinopathies: progress and future challenges. Hum Mol Genet 28(R1):R24–R3010.1093/hmg/ddz172 ↗
8. Maestro S et al (2021) Novel vectors and approaches for gene therapy in liver diseases. JHEP Reports 3(4):10030010.1016/j.jhepr.2021.100300 ↗
9. American Chemical Society (2023) Stimuli-responsive materials for biomedical applications. American Chemical Society, Washington, DC
10. Ashrafizadeh M, Zare EN, Rossi F, Rabiee N, Sharifi E, Makvandi P (2022) Photoactive polymers-decorated Cu-Al layered double hydroxide hexagonal architectures: a potential non-viral vector for photothermal therapy and co-delivery of DOX/pCRISPR. Chem Eng J 448:137747. https://doi.org/10.1016/j.cej.2022.13774710.1016/j.cej.2022.137747 ↗
11. Duan L et al (2021) Exosome-mediated delivery of gene vectors for gene therapy. Nanoscale 13(3):1387–139710.1039/D0NR07622H ↗
12. Ahmadi S et al (2020) Controlled gene delivery systems: nanomaterials and chemical approaches. J Biomed Nanotechnol 16(5):553–58210.1166/jbn.2020.2927 ↗
13. Toudeshkchouei MG et al (2022) Recent approaches to mRNA vaccine delivery by lipid-based vectors prepared by continuous-flow microfluidic devices. Future Med Chem 14(21):1561–158110.4155/fmc-2022-0027 ↗
14. Xu Z et al (2022) Carrier strategies boost the application of CRISPR/Cas system in gene therapy. Exploration. https://doi.org/10.1002/EXP.2021008110.1002/EXP.20210081 ↗
15. Song X et al (2021) Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy. Adv Drug Deliv Rev 168:158–18010.1016/j.addr.2020.04.010 ↗
16. Huang J et al (2022) CRISPR/Cas systems: delivery and application in gene therapy. Front Bioeng Biotechnol 10:94232510.3389/fbioe.2022.942325 ↗
17. Chen F, Alphonse M, Liu Q (2020) Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(3):e160910.1002/wnan.1609 ↗
18. Jinek M et al (2012) A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816–82110.1126/science.1225829 ↗
19. Kingwell K (2023) First CRISPR therapy seeks landmark approval. Nat Rev Drug Discov. https://doi.org/10.1038/d41573-023-00050-810.1038/d41573-023-00050-8 ↗
20. Gasiunas G et al (2012) Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci 109(39):E2579–E258610.1073/pnas.1208507109 ↗
21. Reardon S (2016) First CRISPR clinical trial gets green light from US panel. Nature 531:160–16310.1038/531160a ↗
22. Chen JS et al (2018) CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science 360(6387):436–43910.1126/science.aar6245 ↗
23. Platt RJ et al (2014) CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159(2):440–45510.1016/j.cell.2014.09.014 ↗
24. Cheng Q et al (2020) Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nat Nanotechnol 15(4):313–32010.1038/s41565-020-0669-6 ↗
25. Chowdhry R et al (2023) Enhancing CRISPR/Cas systems with nanotechnology. Trends Biotechnol. https://doi.org/10.1016/j.tibtech.2023.06.00510.1016/j.tibtech.2023.06.005 ↗
26. Yu C et al (2021) Recent advances in stimulus-responsive nanocarriers for gene therapy. Adv Sci 8(14):210054010.1002/advs.202100540 ↗
27. Hu SW et al (2023) Nanobiomaterial vectors for improving gene editing and gene therapy. Mater Today. https://doi.org/10.1016/j.mattod.2023.04.01110.1016/j.mattod.2023.04.011 ↗
28. Rabiee N, Akhavan O, Fatahi Y, Ghadiri AM, Kiani M, Makvandi P, Rabiee M, Nicknam MH, Saeb MR, Varma RS, Ashrafizadeh M, Zare EN, Sharifi E, Lima EC (2022) CaZnO-based nanoghosts for the detection of ssDNA pCRISPR and recombinant SARS-CoV-2 spike antigen and targeted delivery of doxorubicin. Chemosphere 306:135578. https://doi.org/10.1016/j.chemosphere.2022.13557810.1016/j.chemosphere.2022.135578 ↗
29. Rabiee N et al (2021) Turning toxic nanomaterials into a safe and bioactive nanocarrier for co-delivery of DOX/pCRISPR. ACS Appl Bio Mater 4(6):5336–535110.1021/acsabm.1c00447 ↗
30. Rabiee N (2023) Natural components as surface engineering agents for CRISPR delivery. Environ Res 232:11633310.1016/j.envres.2023.116333 ↗
31. Rabiee N et al (2023) Green Biomaterials: fundamental principles. Green Biomater 1–4. https://doi.org/10.1080/29934168.2023.226894310.1080/29934168.2023.2268943 ↗
32. Rabiee N et al (2021) Multifunctional 3D hierarchical bioactive green carbon-based nanocomposites. ACS Sustain Chem Eng 9(26):8706–872010.1021/acssuschemeng.1c00781 ↗
33. Yue H et al (2018) Graphene oxide-mediated Cas9/sgRNA delivery for efficient genome editing. Nanoscale 10(3):1063–107110.1039/C7NR07999K ↗
34. Bagherzadeh M et al (2022) Magnetic carbon–based nanocomposite decorated with palladium complex for co-delivery of DOX/pCRISPR. J Drug Deliv Sci Technol 78:10391710.1016/j.jddst.2022.103917 ↗
35. Zhao Y et al (2021) Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy. ACS Nano 15(4):6517–652910.1021/acsnano.0c08790 ↗
36. Amourizi F et al (2023) Polymeric and composite-based microneedles in drug delivery: regenerative medicine, microbial infection therapy, and cancer treatment. Mater Chem Horizons. https://doi.org/10.22128/mch.2023.645.103610.22128/mch.2023.645.1036 ↗
37. Hasanzadeh A et al (2021) Highly photoluminescent nitrogen-and zinc-doped carbon dots for efficient delivery of CRISPR/Cas9 and mRNA. Bioconjug Chem 32(8):1875–188710.1021/acs.bioconjchem.1c00309 ↗
38. Hasanzadeh A et al (2021) Synthesis and characterization of vitamin D3-functionalized carbon dots for CRISPR/Cas9 delivery. Nanomedicine 16(19):1673–169010.2217/nnm-2021-0038 ↗
39. Dunbar T et al (2022) Carbon nanotube-mediated plasmid DNA delivery in rice leaves and seeds. Int J Mol Sci 23(8):408110.3390/ijms23084081 ↗
40. Santana I et al (2022) Targeted carbon nanostructures for chemical and gene delivery to plant chloroplasts. ACS Nano 16(8):12156–1217310.1021/acsnano.2c02714 ↗
41. Lino CA et al (2018) Delivering CRISPR: a review of the challenges and approaches. Drug Deliv 25(1):1234–125710.1080/10717544.2018.1474964 ↗
42. Das S et al (2023) Comparative ecotoxicity of graphene, functionalized multi-walled CNTs, and their mixture in freshwater microalgae, Scenedesmus obliquus: analyzing the role of oxidative stress. Environ Sci Pollut Res 30(27):70246–7025910.1007/s11356-023-27367-6 ↗
43. Prajapati SK et al (2022) Biomedical applications and toxicities of carbon nanotubes. Drug Chem Toxicol 45(1):435–45010.1080/01480545.2019.1709492 ↗
44. Jahangiri S et al (2022) Viral and non-viral gene therapy using 3D (bio) printing. J Gene Med 24(12):e345810.1002/jgm.3458 ↗
45. Taghavi S et al (2020) Hybrid carbon-based materials for gene delivery in cancer therapy. J Control Release 318:158–17510.1016/j.jconrel.2019.12.030 ↗